Literature DB >> 12424605

Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts.

Wei Hsueh1, Michael S Caplan, Xiao-Wu Qu, Xiao-Di Tan, Isabelle G De Plaen, F Gonzalez-Crussi.   

Abstract

Necrotizing enterocolitis (NEC), a disease affecting predominantly premature infants, is a leading cause of morbidity and mortality in neonatal intensive care units. Although several predisposing factors have been identified, such as prematurity, enteral feeding, and infection, its pathogenesis remains elusive. In the past 20 years, we have established several animal models of NEC in rats and found several endogenous mediators, especially platelet-activating factor (PAF), which may play a pivotal role in NEC. Injection of PAF induces intestinal necrosis, and PAF antagonists prevent the bowel injury induced by bacterial endotoxin, hypoxia, or challenge with tumor necrosis factor-a (TNF) plus endotoxin in adult rats. The same is true for lesions induced by hypoxia and enteral feeding in neonatal animals. Human patients with NEC show high levels of PAF and decreased plasma PAF-acetylhydrolase, the enzyme degrading PAF. The initial event in our experimental models of NEC is probably polymorphonuclear leukocyte (PMN) activation and adhesion to venules in the intestine, which initiates a local inflammatory reaction involving proinflammatory mediators including TNF, complement, prostaglandins, and leukotriene C4. Subsequent norepinephrine release and mesenteric vasoconstriction result in splanchnic ischemia and reperfusion. Bacterial products (e.g., endotoxin) enter the intestinal tissue during local mucosal barrier breakdown, and endotoxin synergizes with PAF to amplify the inflammation. Reactive oxygen species produced by the activated leukocytes and by intestinal epithelial xanthine oxidase may be the final pathway for tissue injury. Protective mechanisms include nitric oxide produced by the constitutive (mainly neuronal) nitric oxide synthase, and indigenous probiotics such as Bifidobacteria infantis. The former maintains intestinal perfusion and the integrity of the mucosal barrier, and the latter keep virulent bacteria in check. The development of tissue injury depends on the balance between injurious and protective mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424605      PMCID: PMC7098425          DOI: 10.1007/s10024-002-0602-z

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  92 in total

1.  Paneth cells and antibacterial host defense in neonatal small intestine.

Authors:  Michael P Sherman; Stephen H Bennett; Freda F Y Hwang; Jan Sherman; Charles L Bevins
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 2.  Necrotising enterocolitis and localised intestinal perforation: different diseases or ends of a spectrum of pathology.

Authors:  V E Boston
Journal:  Pediatr Surg Int       Date:  2006-05-04       Impact factor: 1.827

3.  Candida species differ in their interactions with immature human gastrointestinal epithelial cells.

Authors:  Christina Falgier; Sara Kegley; Heather Podgorski; Timothy Heisel; Kathleen Storey; Catherine M Bendel; Cheryl A Gale
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

4.  Gut mucosal injury in neonates is marked by macrophage infiltration in contrast to pleomorphic infiltrates in adult: evidence from an animal model.

Authors:  Krishnan MohanKumar; Niroop Kaza; Ramasamy Jagadeeswaran; Steven A Garzon; Anchal Bansal; Ashish R Kurundkar; Kopperuncholan Namachivayam; Juan I Remon; C Rekha Bandepalli; Xu Feng; Joern-Hendrik Weitkamp; Akhil Maheshwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-04-26       Impact factor: 4.052

5.  Dynamic change of epidermal growth factor in neonatal rat with intestine injury.

Authors:  Hui Lu; Jun Li; Li-Li Pan; Xin-Dong Xue
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

6.  Colitis locus on chromosome 2 impacting the severity of early-onset disease in mice deficient in GPX1 and GPX2.

Authors:  R Steven Esworthy; Byung-Wook Kim; Garrett P Larson; M L Richard Yip; David D Smith; Min Li; Fong-Fong Chu
Journal:  Inflamm Bowel Dis       Date:  2010-09-24       Impact factor: 5.325

7.  Impaired mucosal regeneration in neonatal necrotising enterocolitis.

Authors:  Daniela Vieten; Anthony Corfield; Daniel Carroll; Pramila Ramani; Richard Spicer
Journal:  Pediatr Surg Int       Date:  2004-12-02       Impact factor: 1.827

Review 8.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

9.  Severe neonatal anemia increases intestinal permeability by disrupting epithelial adherens junctions.

Authors:  Krishnan MohanKumar; Kopperuncholan Namachivayam; Nithya Sivakumar; Natascha G Alves; Venkataramana Sidhaye; Jayanta K Das; Yerin Chung; Jerome W Breslin; Akhil Maheshwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-02-24       Impact factor: 4.052

10.  Epithelial cells in fetal intestine produce chemerin to recruit macrophages.

Authors:  Akhil Maheshwari; Ashish R Kurundkar; Sadiq S Shaik; David R Kelly; Yolanda Hartman; Wei Zhang; Reed Dimmitt; Shehzad Saeed; David A Randolph; Charles Aprahamian; Geeta Datta; Robin K Ohls
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-05-14       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.